Recognition of the molecular mechanisms of cAMP action against DNA damage-induced apoptosis can be useful to improve the efficacy of DNA damaging therapeutic agents. Considering the critical role of bcl-2-associated death promoter (BAD) and p53 proteins in DNA damage -induced apoptosis, the aim of this study was to assess the effect of cAMP-elevating agents on these proteins in doxorubicin-treated pre-B acute lymphoblastic leukemia (pre-B ALL) NALM-6 cells.The pre-B ALL cell line NALM-6 was cultured and treated with doxorubicin in combination with or without cAMP-elevating agents forskolin and 3-isobutyl-1-methylxanthine (IBMX). Cell viability was measured by trypan blue staining and MTT assay. For evaluation of apoptosis, annexin-V staining by flow cytometry and caspase-3 activity assay were used. Protein expression of p53, BAD and phoshorylated BAD was detected by western blotting analysis.cAMP-increasing agents diminished the doxorubicin-mediated cytotoxicity in NALM-6 cells as indicated by the viability assays.
nism of action of these agents is to induce apoptosis proliferation, differentiation and apoptosis (10, 11) . Depending on the cell type and nature of death-inducing signal, diverging effects of cAMP on cell survival have been demonstrated (12) (13) (14) (15) . In many biological systems, the induction of apoptosis requires elevated cAMP. Exposure to cAMP induces apoptosis in ovarian granulosa cells and B-cell chronic lymphocytic leukemia cells (16, 17) . However, elevated cAMP also inhibits apoptosis in a variety of other systems, such as promonocytic leukemia cells exposed to chemotherapeutic drugs (18) and macrophages exposed to nitric oxide (19) . These data indicate cell-type specificity underlying cAMP signaling.
In this study, the effect of cAMP-elevating 
Materials and methods

Cell culture and drug treatment
Pre-B ALL cell line NALM-6 was cultured in suspension in RPMI 1640 medium supplemented with 2 mM L-glutamine, 10% fetal bovine serum (FBS), 100 units/ ml penicillin, and 100 µg/ ml streptomycin in a humidified atmosphere of 5% CO2 at 37 °C. For drug treatment, cells were seeded into a 6-well culture plate at a density of 
Phosphatidylserine (PS) externalization (annexin -V assay)
The effect of cAMP-increasing agents on doxorubicin-induced cell death was assayed by apoptosis analysis. In brief, 24 h after treatment NALM-6 cells were collected and washed with PBS, and 10 6 cells per sample were resuspended in 100 µl incubation buffer. After addition of annexin V-FITC reagent (2 µl per sample), the cell suspension was incubated for 10 min in the dark at room temperature, and fluorescence was measured using Becton-Dickinson FACS. AnnexinVpositive cells were considered to be in apoptotic phase.
Caspase-3 activity assay
To evaluate caspase -3 activity, cell lysates 
Statistical analysis
Statistical analysis was done using SPSS 12. Two Fig. 1 . Doxorubicin-induced cell death was attenuated by cAMP increasing agents. NALM-6 cells were treated with forskolin and IBMX (FI). After 30 min, the pretreated cells were incubated with doxorubicin (250 nM and 500 nM) for 24 h and then cell viability was assessed using trypan blue exclusion assay. Elevated cAMP significantly decreased cell death (* P< 0.05). Significantly, increased phosphorylation of BAD on 99 and 118 serine sites were seen in the cells pretreated with forskolin/IBMX (see fig. 6 ).
Expression of total BAD proteins and phosphorylation of BAD on Ser75 were not affected by doxorubicin and cAMP-elevating agents.
Discussion
In this study, we showed the inhibitory effect of cAMP on DNA damage-induced apoptosis in pre B ALL cell line NALM-6. In addition, we found that cAMP exerts this inhibitory effect through P53 is a tumor suppressor known as major factor in DNA damage-induced apoptosis and loss of p53 that commonly occurs in tumors is thought to be a way to escape from apoptosis. Abrogation of p53 pathway can be caused by genetic mutation (mutated P53) or indirect mechanisms that suppress wild-type p53 (6, 7) . Because the majority of hematologic malignancies express the wild-type p53 (25, 26) , it is of great importance to identify the indirect mechanisms to improve killing of these tumor cells by DNA-damaging therapeutic agents.
Previous studies have been demonstrated that cAMP attenuates p53 protein levels through inhibition of posttranslational modifications (24, 27) . Consistent with previous studies, our finding showed that increased levels of cAMP abrogate total p53 accumulation after exposure of NALM-6 cells to doxorubicin (Fig. 5 ). This finding can introduce the aberrant activation of cAMP signaling pathway as an indirect mechanism that is involved in wild-type p53 suppression. 
